TY  - RPRT
TI  - Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients.
AU  - Sumiyo Watanabe
AU  - Yasuhiro Takeuchi
AU  - Seiji Fukumoto
AU  - Hiroko Fujita
AU  - Tadasumi Nakano
AU  - Toshiro Fujita
PY  - 2003
DO  - 10.1007/s007740300026
UR  - https://pubmed.ncbi.nlm.nih.gov/12720051/
ID  - 12720051
ER  -